These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9815571)

  • 1. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
    Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
    Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
    Ganesh S; Sier CF; Griffioen G; Vloedgraven HJ; de Boer A; Welvaart K; van de Velde CJ; van Krieken JH; Verheijen JH; Lamers CB
    Cancer Res; 1994 Aug; 54(15):4065-71. PubMed ID: 8033138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
    de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Lamers CB
    Cancer Res; 1987 Sep; 47(17):4654-7. PubMed ID: 3621160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
    Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
    Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of urokinase-type plasminogen activator in human gliomas.
    Hsu DW; Efird JT; Hedley-Whyte ET
    Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator profiles in neoplastic tissues of the human colon.
    de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Dooijewaard G; van den Ingh HF; Lamers CB
    Cancer Res; 1988 Aug; 48(16):4520-4. PubMed ID: 3260815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
    Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
    Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
    Jang SH; Min KW; Paik SS; Jang KS
    J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
    Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
    Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of surgical therapy of colon cancer. Results of the Colorectal Cancer Study Group].
    Hermanek P; Wiebelt H; Riedl S; Staimmer D; Hermanek P
    Chirurg; 1994 Apr; 65(4):287-97. PubMed ID: 8020349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
    Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
    Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione S-transferase pi in colorectal tumors is predictive for overall survival.
    Mulder TP; Verspaget HW; Sier CF; Roelofs HM; Ganesh S; Griffioen G; Peters WH
    Cancer Res; 1995 Jun; 55(12):2696-702. PubMed ID: 7780987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas.
    Fujii T; Obara T; Tanno S; Ura H; Kohgo Y
    Hepatogastroenterology; 1999; 46(28):2299-308. PubMed ID: 10521987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.